Frontlight ResearchEarly access
Trial site
Azienda Socio Sanitaria Territoriale Della Valtellina E Dell Alto Lario
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Colorectal cancer2 trials
- Follicular lymphoma2 trials
- Deep vein thrombosis and pulmonary embolism1 trial
- Ovarian cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Amgen1 trial
- ARCAGY/ GINECO GROUP1 trial
- Arianna Anticoagulazione Foundation1 trial
- AstraZeneca1 trial
- Fondazione Italiana Linfomi - ETS1 trial
- and 4 more
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
Active, not recruiting
Recruiting
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Follicular lymphoma1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026